Global Antiretroviral Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Antiretroviral Drug Market Overview

• 1.1 Product Overview and Scope of Antiretroviral Drug
• 1.2 Classification of Antiretroviral Drug by Types
  • 1.2.1 Global Antiretroviral Drug Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Antiretroviral Drug Revenue Market Share by Types in 2018
  • 1.2.3 Multi-Class Drugs Combination
  • 1.2.4 NRTI
  • 1.2.5 NNRTI
  • 1.2.6 Protease Inhibitors
  • 1.2.7 Other
• 1.3 Global Antiretroviral Drug Market by Application
  • 1.3.1 Global Antiretroviral Drug Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Pharmaceutical Companies
  • 1.3.4 Other
• 1.4 Global Antiretroviral Drug Market by Regions
  • 1.4.1 Global Antiretroviral Drug Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Antiretroviral Drug Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Antiretroviral Drug Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antiretroviral Drug Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Antiretroviral Drug Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antiretroviral Drug Status and Prospect (2014-2024)
• 1.5 Global Market Size of Antiretroviral Drug (2014-2024)

2 Manufacturers Profiles

• 2.1 Gilead Sciences
  • 2.1.1 Business Overview
  • 2.1.2 Antiretroviral Drug Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Gilead Sciences Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 ViiV Healthcare
  • 2.2.1 Business Overview
  • 2.2.2 Antiretroviral Drug Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 ViiV Healthcare Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Bristol-Myer Squibb
  • 2.3.1 Business Overview
  • 2.3.2 Antiretroviral Drug Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Bristol-Myer Squibb Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 AbbVie
  • 2.4.1 Business Overview
  • 2.4.2 Antiretroviral Drug Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 AbbVie Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Boehringer-Ingelheim
  • 2.5.1 Business Overview
  • 2.5.2 Antiretroviral Drug Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Boehringer-Ingelheim Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Johnson and Johnson
  • 2.6.1 Business Overview
  • 2.6.2 Antiretroviral Drug Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Johnson and Johnson Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Merck
  • 2.7.1 Business Overview
  • 2.7.2 Antiretroviral Drug Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Merck Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 CIPLA
  • 2.8.1 Business Overview
  • 2.8.2 Antiretroviral Drug Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 CIPLA Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)

3 Global Antiretroviral Drug Market Competition, by Players

• 3.1 Global Antiretroviral Drug Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Antiretroviral Drug Players Market Share
  • 3.2.2 Top 10 Antiretroviral Drug Players Market Share
• 3.3 Market Competition Trend

4 Global Antiretroviral Drug Market Size by Regions

• 4.1 Global Antiretroviral Drug Revenue and Market Share by Regions
• 4.2 North America Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 4.3 Europe Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 4.5 South America Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Antiretroviral Drug Revenue and Growth Rate (2014-2019)

5 North America Antiretroviral Drug Revenue by Countries

• 5.1 North America Antiretroviral Drug Revenue by Countries (2014-2019)
• 5.2 USA Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 5.3 Canada Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Antiretroviral Drug Revenue and Growth Rate (2014-2019)

6 Europe Antiretroviral Drug Revenue by Countries

• 6.1 Europe Antiretroviral Drug Revenue by Countries (2014-2019)
• 6.2 Germany Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 6.3 UK Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 6.4 France Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 6.5 Russia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 6.6 Italy Antiretroviral Drug Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Antiretroviral Drug Revenue by Countries

• 7.1 Asia-Pacific Antiretroviral Drug Revenue by Countries (2014-2019)
• 7.2 China Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 7.3 Japan Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 7.4 Korea Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 7.5 India Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Antiretroviral Drug Revenue and Growth Rate (2014-2019)

8 South America Antiretroviral Drug Revenue by Countries

• 8.1 South America Antiretroviral Drug Revenue by Countries (2014-2019)
• 8.2 Brazil Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Antiretroviral Drug Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Antiretroviral Drug by Countries

• 9.1 Middle East and Africa Antiretroviral Drug Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 9.3 UAE Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Antiretroviral Drug Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Antiretroviral Drug Revenue and Growth Rate (2014-2019)

10 Global Antiretroviral Drug Market Segment by Type

• 10.1 Global Antiretroviral Drug Revenue and Market Share by Type (2014-2019)
• 10.2 Global Antiretroviral Drug Market Forecast by Type (2019-2024)
• 10.3 Multi-Class Drugs Combination Revenue Growth Rate (2014-2024)
• 10.4 NRTI Revenue Growth Rate (2014-2024)
• 10.5 NNRTI Revenue Growth Rate (2014-2024)
• 10.6 Protease Inhibitors Revenue Growth Rate (2014-2024)
• 10.7 Other Revenue Growth Rate (2014-2024)

11 Global Antiretroviral Drug Market Segment by Application

• 11.1 Global Antiretroviral Drug Revenue Market Share by Application (2014-2019)
• 11.2 Antiretroviral Drug Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Pharmaceutical Companies Revenue Growth (2014-2019)
• 11.5 Other Revenue Growth (2014-2019)

12 Global Antiretroviral Drug Market Size Forecast (2019-2024)

• 12.1 Global Antiretroviral Drug Market Size Forecast (2019-2024)
• 12.2 Global Antiretroviral Drug Market Forecast by Regions (2019-2024)
• 12.3 North America Antiretroviral Drug Revenue Market Forecast (2019-2024)
• 12.4 Europe Antiretroviral Drug Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Antiretroviral Drug Revenue Market Forecast (2019-2024)
• 12.6 South America Antiretroviral Drug Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Antiretroviral Drug Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology